SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-22-000027
Filing Date
2022-08-08
Accepted
2022-08-08 16:11:29
Documents
87
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20220630.htm   iXBRL 10-Q 1619313
2 EX-31.1 plrx-20220630xex3111.htm EX-31.1 10530
3 EX-31.2 plrx-20220630xex3121.htm EX-31.2 10498
4 EX-32.1 plrx-20220630xex3211.htm EX-32.1 7371
  Complete submission text file 0001746473-22-000027.txt   6793132

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20220630.xsd EX-101.SCH 56789
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20220630_cal.xml EX-101.CAL 52439
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20220630_def.xml EX-101.DEF 267970
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20220630_lab.xml EX-101.LAB 611294
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20220630_pre.xml EX-101.PRE 417283
81 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20220630_htm.xml XML 920561
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 221144475
SIC: 2834 Pharmaceutical Preparations